DMS_id,DMS_filename,UniProt_ID,taxon,source_organism,target_seq,seq_len,includes_multiple_mutants,DMS_total_number_mutants,DMS_number_single_mutants,DMS_number_multiple_mutants,DMS_binarization_cutoff,DMS_binarization_method,first_author,title,year,jo,region_mutated,molecule_name,selection_assay,selection_type,MSA_filename,MSA_start,MSA_end,MSA_len,MSA_bitscore,MSA_theta,MSA_num_seqs,MSA_perc_cov,MSA_num_cov,MSA_N_eff,MSA_Neff_L,MSA_Neff_L_category,MSA_num_significant,MSA_num_significant_L,raw_DMS_filename,raw_DMS_phenotype_name,raw_DMS_directionality,raw_DMS_mutant_column,weight_file_name,pdb_file,ProteinGym_version,raw_mut_offset,coarse_selection_type
A4_HUMAN_Seuma_2022,A4_HUMAN_Seuma_2022.csv,A4_HUMAN,Human,Homo sapiens,MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN,770,TRUE,14811,796,14015,-2,manual,Seuma,"An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation",2022,10.1038/s41467-022-34742-3,672-713,APP,aggregation,survival assessment assay,A4_HUMAN_2023-08-07_b01.a2m,1,770,770,0.1,0.2,5272,0.987,760,99.3,0.130657895,Low,0,0,MS_BL_BB_indels_processed_data.tsv,nscore,1,mutant,A4_HUMAN_theta0.2_2023-08-07_b01.npy,A4_HUMAN.pdb,1,,Stability
ACE2_HUMAN_Chan_2020,ACE2_HUMAN_Chan_2020.csv,ACE2_HUMAN,Human,Homo sapiens,MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVMGVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF,805,FALSE,2223,2223,0,-0.266564268,median,Chan,Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2,2020,10.1126/science.abc0870,19-518,ACE2,Binding affinity,Flow Cytometry Assay,ACE2_HUMAN_2023-10-12_b05.a2m,1,805,805,0.5,0.2,11106,0.743,598,1506.7,"2,519,565,217",Medium,349,0.58361204,,score,1,mutant,ACE2_HUMAN_theta0.2_2023-10-12_b05.npy,ACE2_HUMAN.pdb,1,,Binding
ADRB2_HUMAN_Jones_2020,ADRB2_HUMAN_Jones_2020.csv,ADRB2_HUMAN,Human,Homo sapiens,MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL,413,FALSE,7800,7800,0,2,median,Jones,Structural and Functional Characterization of G Protein-Coupled Receptors with Deep Mutational Scanning,2020,10.7554/eLife.54895,2-413,ADRB2,"transcription (luciferase reporter, isoproterenol (beta2AR agonist)-induced)",Receptor activity,ADRB2_HUMAN_full_11-26-2021_b03.a2m,1,413,413,0.3,0.2,204722,0.712,294,25459.6,"8,659,727,891",medium,234,0.795918367,ADRB2_HUMAN_Jones_2020.csv,0.625,1,mutant_id,ADRB2_HUMAN_theta_0.2.npy,ADRB2_HUMAN.pdb,0.1,,Activity
AICDA_HUMAN_Gajula_2014_3cycles,AICDA_HUMAN_Gajula_2014_3cycles.csv,AICDA_HUMAN,Human,Homo sapiens,MDSLLMNRRKFLYQFKNVRWAKGRRETYLCYVVKRRDSATSFSLDFGYLRNKNGCHVELLFLRYISDWDLDPGRCYRVTWFTSWSPCYDCARHVADFLRGNPNLSLRIFTARLYFCEDRKAEPEGLRRLHRAGVQIAIMTFKDYFYCWNTFVENHERTFKAWEGLHENSVRLSRQLRRILLPLYEVDDLRDAFRTLGL,198,FALSE,209,209,0,1,manual,Gajula,High-throughput mutagenesis reveals functional determinants for DNA targeting by activation-induced deaminase,2014,10.1093/nar/gku689,113-123,AID,Enzymatic activity,bulk RNA-sequencing,AICDA_HUMAN_2023-08-07_b01.a2m,1,198,198,0.1,0.2,18148,0.879,174,3340,"191,954,023",Medium,101,0.58045977,urn_mavedb_00000106-c-1_scores.csv,DMS_score,1,mutant,AICDA_HUMAN_theta0.2_2023-08-07_b01.npy,AICDA_HUMAN.pdb,1,,Activity
AMFR_HUMAN_Tsuboyama_2023_4G3O,AMFR_HUMAN_Tsuboyama_2023_4G3O.csv,AMFR_HUMAN,Human,Homo sapiens,YFQGQLNAMAHQIQEMFPQVPYHLVLQDLQLTRSVEITTDNILEGRI,47,TRUE,2972,820,2152,"-1,504,736,022",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-6,Jan-47,E3 ubiquitin-protein ligase AMFR,Stability,cDNA display proteolysis,AMFR_HUMAN_2023-08-07_b04.a2m,1,47,47,0.4,0.2,17787,0.872,41,1166.9,"2,846,097,561",Medium,12,0.292682927,Tsuboyama2023_Dataset2_Dataset3,ddG_ML_float,1,mut_type,AMFR_HUMAN_theta0.2_2023-08-07_b04.npy,AMFR_HUMAN.pdb,1,,Stability
B2L11_HUMAN_Dutta_2010_binding-Mcl-1,B2L11_HUMAN_Dutta_2010_binding-Mcl-1.csv,B2L11_HUMAN,Human,Homo sapiens,MAKQPSDVSSECDREGRQLQPAERPPQLRPGAPTSLQTEPQGNPEGNHGGEGDSCPHGSPQGPLAPPASPGPFATRSPLFIFMRRSSLLSRSSSGYFSFDTDRSPAPMSCDKSTQTPSPPCQAFNHYLSAMASMRQAEPADMRPEIWIAQELRRIGDEFNAYYARRVFLNNYQAAEDHPRMVILRLLRYIVRLVWRMH,198,FALSE,170,170,0,16002529.37,median,Dutta,Determinants of BH3 Binding Specificity for Mcl-1 versus Bcl-xL,2010,10.1016/j.jmb.2010.03.058,148-159,BCL2L11,Binding to Mcl-1 (FACS; yeast-displayed and antibody stained for binding partner),FACS,B2L11_HUMAN_2023-08-07_b04.a2m,1,198,198,0.4,0.2,660,0.995,197,88.5,0.449238579,Low,2,0.010152284,,score,1,mut_proteingym,B2L11_HUMAN_theta0.2_2023-08-07_b04.npy,B2L11_HUMAN.pdb,1,147,Binding
BRCA1_HUMAN_Findlay_2018,BRCA1_HUMAN_Findlay_2018.csv,BRCA1_HUMAN,Human,Homo sapiens,MDLSALRVEEVQNVINAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLKIICAFQLDTGLEYANSYNFAKKENNSPEHLKDEVSIIQSMGYRNRAKRLLQSEPENPSLQETSLSVQLSNLGTVRTLRTKQRIQPQKTSVYIELGSDSSEDTVNKATYCSVGDQELLQITPQGTRDEISLDSAKKAACEFSETDVTNTEHHQPSNNDLNTTEKRAAERHPEKYQGSSVSNLHVEPCGTNTHASSLQHENSSLLLTKDRMNVEKAEFCNKSKQPGLARSQHNRWAGSKETCNDRRTPSTEKKVDLNADPLCERKEWNKQKLPCSENPRDTEDVPWITLNSSIQKVNEWFSRSDELLGSDDSHDGESESNAKVADVLDVLNEVDEYSGSSEKIDLLASDPHEALICKSERVHSKSVESNIEDKIFGKTYRKKASLPNLSHVTENLIIGAFVTEPQIIQERPLTNKLKRKRRPTSGLHPEDFIKKADLAVQKTPEMINQGTNQTEQNGQVMNITNSGHENKTKGDSIQNEKNPNPIESLEKESAFKTKAEPISSSISNMELELNIHNSKAPKKNRLRRKSSTRHIHALELVVSRNLSPPNCTELQIDSCSSSEEIKKKKYNQMPVRHSRNLQLMEGKEPATGAKKSNKPNEQTSKRHDSDTFPELKLTNAPGSFTKCSNTSELKEFVNPSLPREEKEEKLETVKVSNNAEDPKDLMLSGERVLQTERSVESSSISLVPGTDYGTQESISLLEVSTLGKAKTEPNKCVSQCAAFENPKGLIHGCSKDNRNDTEGFKYPLGHEVNHSRETSIEMEESELDAQYLQNTFKVSKRQSFAPFSNPGNAEEECATFSAHSGSLKKQSPKVTFECEQKEENQGKNESNIKPVQTVNITAGFPVVGQKDKPVDNAKCSIKGGSRFCLSSQFRGNETGLITPNKHGLLQNPYRIPPLFPIKSFVKTKCKKNLLEENFEEHSMSPEREMGNENIPSTVSTISRNNIRENVFKEASSSNINEVGSSTNEVGSSINEIGSSDENIQAELGRNRGPKLNAMLRLGVLQPEVYKQSLPGSNCKHPEIKKQEYEEVVQTVNTDFSPYLISDNLEQPMGSSHASQVCSETPDDLLDDGEIKEDTSFAENDIKESSAVFSKSVQKGELSRSPSPFTHTHLAQGYRRGAKKLESSEENLSSEDEELPCFQHLLFGKVNNIPSQSTRHSTVATECLSKNTEENLLSLKNSLNDCSNQVILAKASQEHHLSEETKCSASLFSSQCSELEDLTANTNTQDPFLIGSSKQMRHQSESQGVGLSDKELVSDDEERGTGLEENNQEEQSMDSNLGEAASGCESETSVSEDCSGLSSQSDILTTQQRDTMQHNLIKLQQEMAELEAVLEQHGSQPSNSYPSIISDSSALEDLRNPEQSTSEKAVLTSQKSSEYPISQNPEGLSADKFEVSADSSTSKNKEPGVERSSPSKCPSLDDRWYMHSCSGSLQNRNYPSQEELIKVVDVEEQQLEESGPHDLTETSYLPRQDLEGTPYLESGISLFSDDPESDPSEDRAPESARVGNIPSSTSALKVPQLKVAESAQSPAAAHTTDTAGYNAMEESVSREKPELTASTERVNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY,1863,FALSE,1837,1837,0,-1,manual,Findlay,Accurate classification of BRCA1 variants with saturation genome editing,2018,10.1038/s41586-018-0461-z,1-1855,BRCA1,Growth,Growth,BRCA1_HUMAN_full_11-26-2021_b02.a2m,1,1863,1863,0.2,0.2,1008,0.769,1432,108.4,0.075698324,low,0,0,BRCA1_HUMAN_Findlay_2018.csv,function_score,1,mutant,BRCA1_HUMAN_theta_0.2.npy,BRCA1_HUMAN.pdb,0.1,,OrganismalFitness
BRCA2_HUMAN_Erwood_2022_HEK293T,BRCA2_HUMAN_Erwood_2022_HEK293T.csv,BRCA2_HUMAN,Human,Homo sapiens,MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPNLFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTVKTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESLKKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVVDTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEPNDTDPLDSNVANQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCDQNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDCILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGLEIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSYKGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLTSSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCENDPKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLSNLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYMRVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNNLALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVKQHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLSEHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSDCKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKSTFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDCNKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISLSSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENEDNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQIKEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAKESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTGNQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFSHQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNLCRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTSVSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYLSNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAYPQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIKKVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKVFADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFSTASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLISQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQNVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQDKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSENYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILVGEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKERQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTGRPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKNNSNQAVAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPRISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQLADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPKEFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANISETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVGSPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDVIIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENTTKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKKQAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLLTEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKFLDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLIAASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKLMHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSVSTPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQPPRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEKQFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI,3418,FALSE,265,265,0,0.8,manual,Erwood,Saturation variant interpretation using CRISPR prime editing,2022,10.1038/s41587-021-01201-1,388-2654,BRCA2,Fitness,Growth,BRCA2_HUMAN_2023-10-12_b01.a2m,1,3418,3418,0.1,0.2,933,,,,,,,,41587_2021_1201_MOESM3_ESM.xlsx,Function Score,1,Protein Annotation,BRCA2_HUMAN_theta0.2_2023-10-12_b01.npy,BRCA2_HUMAN_1-1000.pdb,1,,OrganismalFitness
CALM1_HUMAN_Weile_2017,CALM1_HUMAN_Weile_2017.csv,CALM1_HUMAN,Human,Homo sapiens,MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK,149,FALSE,1813,1813,0,0.872790117,median,Weile,A framework for exhaustively mapping functional missense variants,2017,10.15252/msb.20177908,2-149,CALM1,Yeast growth,complementation,CALM1_HUMAN_full_11-26-2021_b03.a2m,1,149,149,0.3,0.2,177633,0.893,133,28985.1,"2,179,330,827",high,96,0.721804511,CALM1_HUMAN_Weile_2017.csv,screenscore,1,mutant,CALM1_HUMAN_theta_0.2.npy,CALM1_HUMAN.pdb,0.1,,OrganismalFitness
CAR11_HUMAN_Meitlis_2020_lof,CAR11_HUMAN_Meitlis_2020_lof.csv,CAR11_HUMAN,Human,Homo sapiens,MPGGGPEMDDYMETLKDEEDALWENVECNRHMLSRYINPAKLTPYLRQCKVIDEQDEDEVLNAPMLPSKINRAGRLLDILHTKGQRGYVVFLESLEFYYPELYKLVTGKEPTRRFSTIVVEEGHEGLTHFLMNEVIKLQQQMKAKDLQRCELLARLRQLEDEKKQMTLTRVELLTFQERYYKMKEERDSYNDELVKVKDDNYNLAMRYAQLSEEKNMAVMRSRDLQLEIDQLKHRLNKMEEECKLERNQSLKLKNDIENRPKKEQVLELERENEMLKTKNQELQSIIQAGKRSLPDSDKAILDILEHDRKEALEDRQELVNRIYNLQEEARQAEELRDKYLEEKEDLELKCSTLGKDCEMYKHRMNTVMLQLEEVERERDQAFHSRDEAQTQYSQCLIEKDKYRKQIRELEEKNDEMRIEMVRREACIVNLESKLRRLSKDSNNLDQSLPRNLPVTIISQDFGDASPRTNGQEADDSSTSEESPEDSKYFLPYHPPQRRMNLKGIQLQRAKSPISLKRTSDFQAKGHEEEGTDASPSSCGSLPITNSFTKMQPPRSRSSIMSITAEPPGNDSIVRRYKEDAPHRSTVEEDNDSGGFDALDLDDDSHERYSFGPSSIHSSSSSHQSEGLDAYDLEQVNLMFRKFSLERPFRPSVTSVGHVRGPGPSVQHTTLNGDSLTSQLTLLGGNARGSFVHSVKPGSLAEKAGLREGHQLLLLEGCIRGERQSVPLDTCTKEEAHWTIQRCSGPVTLHYKVNHEGYRKLVKDMEDGLITSGDSFYIRLNLNISSQLDACTMSLKCDDVVHVRDTMYQDRHEWLCARVDPFTDHDLDMGTIPSYSRAQQLLLVKLQRLMHRGSREEVDGTHHTLRALRNTLQPEEALSTSDPRVSPRLSRASFLFGQLLQFVSRSENKYKRMNSNERVRIISGSPLGSLARSSLDATKLLTEKQEELDPESELGKNLSLIPYSLVRAFYCERRRPVLFTPTVLAKTLVQRLLNSGGAMEFTICKSDIVTRDEFLRRQKTETIIYSREKNPNAFECIAPANIEAVAAKNKHCLLEAGIGCTRDLIKSNIYPIVLFIRVCEKNIKRFRKLLPRPETEEEFLRVCRLKEKELEALPCLYATVEPDMWGSVEELLRVVKDKIGEEQRKTIWVDEDQL,1154,FALSE,2395,2395,0,-0.4635,manual,Meitlis,Multiplexed Functional Assessment of Genetic Variants in CARD11,2020,10.1016/j.ajhg.2020.10.015.,4-146,CARD11,Signaling,survival assessment assay,CAR11_HUMAN_2023-10-12_b02.a2m,1,1154,1154,0.2,0.2,1352,0.998,1152,53.7,0.046614583,Low,0,0,mmc3.xlsx,log2_score,1,mutant,CAR11_HUMAN_theta0.2_2023-10-12_b02.npy,CAR11_HUMAN.pdb,1,,OrganismalFitness
CASP3_HUMAN_Roychowdhury_2020,CASP3_HUMAN_Roychowdhury_2020.csv,CASP3_HUMAN,Human,Homo sapiens,MSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHLEHHHHHH,258,FALSE,1567,1567,0,0.03725973,median,Roychowdhury,Microfluidic deep mutational scanning of the human executioner caspases reveals differences in structure and regulation,2022,10.1038/s41420-021-00799-0,2-258,CASP3,Fluorescence measurement,,CASP3_HUMAN_2023-08-07_b01.a2m,1,258,258,0.1,0.2,86012,0.884,228,28096.2,"1,232,289,474",High,307,"1,346,491,228",CASP3_HUMAN_Roychowdhury_2020.csv,coef,1,mutant,CASP3_HUMAN_theta0.2_2023-08-07_b01.npy,CASP3_HUMAN.pdb,1,,Activity
CASP7_HUMAN_Roychowdhury_2020,CASP7_HUMAN_Roychowdhury_2020.csv,CASP7_HUMAN,Human,Homo sapiens,MAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ,281,FALSE,1680,1680,0,-0.334076807,median,Roychowdhury,Microfluidic deep mutational scanning of the human executioner caspases reveals differences in structure and regulation,2022,10.1038/s41420-021-00799-0,2-281,CASP7,Fluorescence measurement,,CASP7_HUMAN_2023-08-07_b01.a2m,1,281,281,0.1,0.2,71075,0.854,240,21588.4,"8,995,166,667",Medium,298,"1,241,666,667",CASP7_HUMAN_Roychowdhury_2020.csv,coef,1,mutant,CASP7_HUMAN_theta0.2_2023-08-07_b01.npy,CASP7_HUMAN.pdb,1,,Activity
CBPA2_HUMAN_Tsuboyama_2023_1O6X,CBPA2_HUMAN_Tsuboyama_2023_1O6X.csv,CBPA2_HUMAN,Human,Homo sapiens,VGDQVLEIVPSNEEQIKNLLQLEAQEHLQLDFWKSPTTPGETAHVRVPFVNVQAVKVFLESQGIAYSIMIED,72,TRUE,2068,1357,711,"-1,221,174,658",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-11,Jan-72,Carboxypeptidase A2,Stability,cDNA display proteolysis,CBPA2_HUMAN_2023-08-07_b03.a2m,1,72,72,0.3,0.2,12711,0.986,71,3086.5,"4,347,183,099",Medium,34,0.478873239,Tsuboyama2023_Dataset2_Dataset8,ddG_ML_float,1,mut_type,CBPA2_HUMAN_theta0.2_2023-08-07_b03.npy,CBPA2_HUMAN.pdb,1,,Stability
CBS_HUMAN_Sun_2020,CBS_HUMAN_Sun_2020.csv,CBS_HUMAN,Human,Homo sapiens,MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK,551,FALSE,7217,7217,0,0.375391013,median,Sun,A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase,2020,10.1186/s13073-020-0711-1,2-551,cystathionine beta-synthase,Yeast Growth,Growth,CBS_HUMAN_2023-10-12_b08.a2m,1,551,551,0.8,0.2,19563,0.833,459,1886,"4,108,932,462",Medium,289,0.62962963,,score,1,mutant,CBS_HUMAN_theta0.2_2023-10-12_b08.npy,CBS_HUMAN.pdb,1,,OrganismalFitness
CBX4_HUMAN_Tsuboyama_2023_2K28,CBX4_HUMAN_Tsuboyama_2023_2K28.csv,CBX4_HUMAN,Human,Homo sapiens,AVESIEKKRIRKGRVEYLVKWRGWSPKYNTWEPEENILDPRLLIAFQNRE,50,TRUE,2282,917,1365,"-1,635,037,732",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-12,Jan-50,E3 SUMO-protein ligase CBX4,Stability,cDNA display proteolysis,CBX4_HUMAN_2023-08-07_b03.a2m,1,50,50,0.3,0.2,108263,0.96,48,13404.4,"2,792,583,333",High,23,0.479166667,Tsuboyama2023_Dataset2_Dataset9,ddG_ML_float,1,mut_type,CBX4_HUMAN_theta0.2_2023-08-07_b03.npy,CBX4_HUMAN.pdb,1,,Stability
CCR5_HUMAN_Gill_2023,CCR5_HUMAN_Gill_2023.csv,CCR5_HUMAN,Human,Homo sapiens,MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSSHFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTIMIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL,352,FALSE,6137,6137,0,-0.06,median,Gill,Multiple mechanisms of self-association of chemokine receptors CXCR4 and CCR5 demonstrated by deep mutagenesis,2023,10.1101/2023.03.25.534231,2-344,CCR5,"binding affinity, surface expression",FACS,CCR5_HUMAN_2023-08-07_b03.a2m,1,352,352,0.3,0.2,632074,0.83,292,63056,"2,159,452,055",High,309,"1,058,219,178",,avg_score,1,mutant,CCR5_HUMAN_theta0.2_2023-08-07_b03.npy,CCR5_HUMAN.pdb,1,,Binding
CD19_HUMAN_Klesmith_2019_FMC_singles,CD19_HUMAN_Klesmith_2019_FMC_singles.csv,CD19_HUMAN,Human,Homo sapiens,MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKPFLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGELFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSLNQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMWVMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYLIFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSGLGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEFYENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLSPHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGPDPAWGGGGRMGTWSTR,556,FALSE,3761,3761,0,0,manual,Klesmith,Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins,2019,10.1021/acs.molpharmaceut.9b00418,20-291,CD19,Binding affinity,FACS,CD19_HUMAN_2023-10-12_b01.a2m,1,556,556,0.1,0.2,1183,1,556,275.2,0.494964029,Low,11,0.019784173,single-site/Clinical_FMC_T1_Fitness.tsv,Fitness,1,mutant_offset,CD19_HUMAN_theta0.2_2023-10-12_b01.npy,CD19_HUMAN.pdb,1,,Binding
CP2C9_HUMAN_Amorosi_2021_abundance,CP2C9_HUMAN_Amorosi_2021_abundance.csv,CP2C9_HUMAN,Human,Homo sapiens,MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPV,490,FALSE,6370,6370,0,0.772324435,median,Amorosi,Massively parallel characterization of CYP2C9 variant enzyme activity and abundance,2021,10.1016/j.ajhg.2021.07.001,2-490,Cytochrome P450 2C9,protein abundance,protein abundance,CP2C9_HUMAN_full_11-26-2021_b04.a2m,1,490,490,0.4,0.2,264279,0.886,434,81212.1,"1,871,246,544",high,1092,"2,516,129,032",CP2C9_HUMAN_Amorosi_2021.csv,abundance_score,1,variant,CP2C9_HUMAN_theta_0.2.npy,CP2C9_HUMAN.pdb,0.1,,Expression
DLG4_HUMAN_Faure_2021,DLG4_HUMAN_Faure_2021.csv,DLG4_HUMAN,Human,Homo sapiens,MDCLCIVTTKKYRYQDEDTPPLEHSPAHLPNQANSPPVIVNTDTLEAPGYELQVNGTEGEMEYEEITLERGNSGLGFSIAGGTDNPHIGDDPSIFITKIIPGGAAAQDGRLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIVRLYVMRRKPPAEKVMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGRLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVVYLKVAKPSNAYLSDSYAPPDITTSYSQHLDNEISHSSYLGTDYPTAMTPTSPRRYSPVAKDLLGEEDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAKIHDLREQLMNSSLGSGTASLRSNPKRGFYIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDASDEEWWQARRVHSDSETDDIGFIPSKRRVERREWSRLKAKDWGSSSGSQGREDSVLSYETVTQMEVHYARPIIILGPTKDRANDDLLSEFPDKFGSCVPHTTRPKREYEIDGRDYHFVSSREKMEKDIQAHKFIEAGQYNSHLYGTSVQSVREVAEQGKHCILDVSANAVRRLQAAHLHPIAIFIRPRSLENVLEINKRITEEQARKAFDRATKLEQEFTECFSAIVEGDSFEEIYHKVKRVIEDLSGPYIWVPARERL,724,TRUE,6976,1280,5696,-0.560258533,median,Faure,Mapping the energetic and allosteric landscapes of protein binding domains,2022,10.1038/s41586-022-04586-4,311-394,PSD95-PDZ3,Yeast growth,Growth,DLG4_HUMAN_full_11-26-2021_b02.a2m,1,724,724,0.2,0.2,25338,0.825,597,354.3,0.593467337,low,7,0.011725293,DLG4_HUMAN_Faure_2021.csv,fitness,1,mutant,DLG4_HUMAN_theta_0.2.npy,DLG4_HUMAN.pdb,0.1,,OrganismalFitness
DNJA1_HUMAN_Tsuboyama_2023_2LO1,DNJA1_HUMAN_Tsuboyama_2023_2LO1.csv,DNJA1_HUMAN,Human,Homo sapiens,TTYYDVLGVKPNATQEELKKAYRKLALKYHPDKNPNEGEKFKQISQAYEVLSDAKKRELYDKGGE,65,TRUE,2264,1216,1048,"-2,239,788,161",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-16,Jan-65,DnaJ homolog subfamily A member 1,Stability,cDNA display proteolysis,DNJA1_HUMAN_2023-08-07_b07.a2m,1,65,65,0.7,0.2,280284,0.969,63,35361.9,561.3,High,52,0.825396825,Tsuboyama2023_Dataset2_Dataset13,ddG_ML_float,1,mut_type,DNJA1_HUMAN_theta0.2_2023-08-07_b07.npy,DNJA1_HUMAN.pdb,1,,Stability
EPHB2_HUMAN_Tsuboyama_2023_1F0M,EPHB2_HUMAN_Tsuboyama_2023_1F0M.csv,EPHB2_HUMAN,Human,Homo sapiens,SFNTVDEWLEAIKMGQYKESFANAGFTSFDVVSQMMMEDILRVGVTLAGHQKKILNSIQVMRAQMN,66,TRUE,1960,1239,721,"-1,932,053,964",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-18,Jan-66,Ephrin type-B receptor 2,Stability,cDNA display proteolysis,EPHB2_HUMAN_2023-08-07_b04.a2m,1,66,66,0.4,0.2,212234,0.894,59,8426.3,"1,428,186,441",High,29,0.491525424,Tsuboyama2023_Dataset2_Dataset15,ddG_ML_float,1,mut_type,EPHB2_HUMAN_theta0.2_2023-08-07_b04.npy,EPHB2_HUMAN.pdb,1,,Stability
ERBB2_HUMAN_Elazar_2016,ERBB2_HUMAN_Elazar_2016.csv,ERBB2_HUMAN,Human,Homo sapiens,MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV,1255,FALSE,326,326,0,0.067833938,median,Elazar,Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma membrane,2016,10.7554/eLife.12125,651-674,ErbB2 membrane domain,Membrane-protein insertion,TOXCAT-Beta-lactamase (TbL) screen,ERBB2_HUMAN_2023-10-12_b02.a2m,1,1255,1255,0.2,0.2,8311,0.981,1231,447.9,0.363850528,Low,187,0.151909017,urn_mavedb_00000051-b-1_scores.csv,score,-1,mutant,ERBB2_HUMAN_theta0.2_2023-10-12_b02.npy,ERBB2_HUMAN.pdb,1,650,Expression
FKBP3_HUMAN_Tsuboyama_2023_2KFV,FKBP3_HUMAN_Tsuboyama_2023_2KFV.csv,FKBP3_HUMAN,Human,Homo sapiens,VPQRAWTVEQLRSEQLPKKDIIKFLQEHGSDSFLAEHKLLGNIKNVAKTANKDHLVTAYNHLFETKRFK,69,FALSE,1237,1237,0,-0.1631252,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-20,Jan-69,Peptidyl-prolyl cis-trans isomerase FKBP3,Stability,cDNA display proteolysis,FKBP3_HUMAN_2023-08-07_b03.a2m,1,69,69,0.3,0.2,3216,0.957,66,132,2,Medium,7,0.106060606,Tsuboyama2023_Dataset2_Dataset17,ddG_ML_float,1,mut_type,FKBP3_HUMAN_theta0.2_2023-08-07_b03.npy,FKBP3_HUMAN.pdb,1,,Stability
GDIA_HUMAN_Silverstein_2021,GDIA_HUMAN_Silverstein_2021.csv,GDIA_HUMAN,Human,Homo sapiens,MDEEYDVIVLGTGLTECILSGIMSVNGKKVLHMDRNPYYGGESSSITPLEELYKRFQLLEGPPESMGRGRDWNVDLIPKFLMANGQLVKMLLYTEVTRYLDFKVVEGSFVYKGGKIYKVPSTETEALASNLMGMFEKRRFRKFLVFVANFDENDPKTFEGVDPQTTSMRDVYRKFDLGQDVIDFTGHALALYRTDDYLDQPCLETVNRIKLYSESLARYGKSPYLYPLYGLGELPQGFARLSAIYGGTYMLNKPVDDIIMENGKVVGVKSEGEVARCKQLICDPSYIPDRVRKAGQVIRIICILSHPIKNTNDANSCQIIIPQNQVNRKSDIYVCMISYAHNVAAQGKYIAIASTTVETTDPEKEVEPALELLEPIDQKFVAISDLYEPIDDGCESQVFCSCSYDATTHFETTCNDIKDIYKRMAGTAFDFENMKRKQNDVFGEAEQ,447,FALSE,1154,1154,0,0.842593696,median,Silverstein,A systematic genotype-phenotype map for missense variants in the human intellectual disability-associated gene GDI1,2021,10.1101/2021.10.06.463360,2-447,GDI1,Yeast Growth,Growth,GDIA_HUMAN_2023-10-12_b05.a2m,1,447,447,0.5,0.2,5196,0.996,445,398.1,0.894606742,Low,86,0.193258427,media-1.xlsx,fitness,1,mutant,GDIA_HUMAN_theta0.2_2023-10-12_b05.npy,GDIA_HUMAN.pdb,1,,OrganismalFitness
GLPA_HUMAN_Elazar_2016,GLPA_HUMAN_Elazar_2016.csv,GLPA_HUMAN,Human,Homo sapiens,MYGKIIFVLLLSEIVSISASSTTGVAMHTSTSSSVTKSYISSQTNDTHKRDTYAATPRAHEVSEISVRTVYPPEEETGERVQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIRRLIKKSPSDVKPLPSPDTDVPLSSVEIENPETSDQ,150,FALSE,245,245,0,0.932110578,median,Elazar,Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma membrane,2016,10.7554/eLife.12125,94-108,Glycophorin A membrane domain,Membrane-protein insertion,TOXCAT-Beta-lactamase (TbL) screen,GLPA_HUMAN_2023-10-12_b03.a2m,1,150,150,0.3,0.2,273,1,150,81,0.54,Low,1,0.006666667,urn_mavedb_00000051-c-1_scores.csv,score,-1,mutant,GLPA_HUMAN_theta0.2_2023-10-12_b03.npy,GLPA_HUMAN.pdb,1,93,Expression
GRB2_HUMAN_Faure_2021,GRB2_HUMAN_Faure_2021.csv,GRB2_HUMAN,Human,Homo sapiens,MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV,217,TRUE,63366,1034,62332,-0.7,manual,Faure,Mapping the energetic and allosteric landscapes of protein binding domains,2022,10.1038/s41586-022-04586-4,159-214,GRB2-SH3,Yeast growth,Growth,GRB2_HUMAN_full_11-26-2021_b05.a2m,1,217,217,0.5,0.2,33228,0.816,177,1485.9,"8,394,915,254",medium,42,0.237288136,GRB2_HUMAN_Faure_2021.csv,fitness,1,mutant,GRB2_HUMAN_theta_0.2.npy,GRB2_HUMAN.pdb,0.1,,OrganismalFitness
HECD1_HUMAN_Tsuboyama_2023_3DKM,HECD1_HUMAN_Tsuboyama_2023_3DKM.csv,HECD1_HUMAN,Human,Homo sapiens,NLYFQGLKYMVPGARVTRGLDWKWRDQDGSPQGEGTVTGELHNGWIDVTWDAGGSNSYRMGAEGKFDLKLAP,72,TRUE,5586,1244,4342,-0.7,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-22,Jan-72,E3 ubiquitin-protein ligase HECTD1,Stability,cDNA display proteolysis,HECD1_HUMAN_2023-08-07_b03.a2m,1,72,72,0.3,0.2,18660,0.903,65,1192.3,"1,834,307,692",Medium,24,0.369230769,Tsuboyama2023_Dataset2_Dataset19,ddG_ML_float,1,mut_type,HECD1_HUMAN_theta0.2_2023-08-07_b03.npy,HECD1_HUMAN.pdb,1,,Stability
HEM3_HUMAN_Loggerenberg_2023,HEM3_HUMAN_Loggerenberg_2023.csv,HEM3_HUMAN,Human,Homo sapiens,MSGNGNAAATAEENSPKMRVIRVGTRKSQLARIQTDSVVATLKASYPGLQFEIIAMSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGALGVEVRAKDQDILDLVGVLHDPETLLRCIAERAFLRHLEGGCSVPVAVHTAMKDGQLYLTGGVWSLDGSDSIQETMQATIHVPAQHEDGPEDDPQLVGITARNIPRGPQLAAQNLGISLANLLLSKGAKNILDVARQLNDAH,361,FALSE,5689,5689,0,0.614299046,median,van Loggerenberg,Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation,2023,10.1101/2023.02.06.527353,19-360,hydroxymethylbilane synthase,activity,Yeast complementation,HEM3_HUMAN_2023-08-07_b02.a2m,1,361,361,0.2,0.2,59544,0.85,307,11510.2,"3,749,250,814",Medium,500,"1,628,664,495",,score,1,mutant,HEM3_HUMAN_theta0.2_2023-08-07_b02.npy,HEM3_HUMAN.pdb,1,,Activity
HMDH_HUMAN_Jiang_2019,HMDH_HUMAN_Jiang_2019.csv,HMDH_HUMAN,Human,Homo sapiens,MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSSDIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTGLNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIGVGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFARVLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKRIEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVTQKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNSSLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA,888,FALSE,16853,16853,0,0.48275,median,Jiang,Exhaustive mapping of missense variation in coronary heart disease-related genes,2019,https://hdl.handle.net/1807/98076,2-888,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Fitness,Resistance to statin inhibition,HMDH_HUMAN_2023-10-12_b05.a2m,1,888,888,0.5,0.2,3153,0.995,884,554.6,0.627375566,Low,778,0.880090498,urn_mavedb_00000035-a-1_scores.csv,score,1,mutant,HMDH_HUMAN_theta0.2_2023-10-12_b05.npy,HMDH_HUMAN.pdb,1,,OrganismalFitness
HXK4_HUMAN_Gersing_2022_activity,HXK4_HUMAN_Gersing_2022_activity.csv,HXK4_HUMAN,Human,Homo sapiens ,MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ,465,FALSE,8570,8570,0,0.563165224,median,Gersing,A comprehensive map of human glucokinase variant activity,2022,10.1101/2022.05.04.490571,2-465,glucokinase regulatory protein,functional complementation to reduced growth on glucose medium,enzymatic activity,HXK4_HUMAN_b0.1.a2m,1,465,465,0.1,0.2,23354,1,465,2336.1,"5,023,870,968",Medium,181,0.389247312,HXK4_HUMAN_Gersing_2022.csv,score,1,mutant,HXK4_HUMAN_theta_0.2.npy,HXK4_HUMAN.pdb,1,,OrganismalFitness
ILF3_HUMAN_Tsuboyama_2023_2L33,ILF3_HUMAN_Tsuboyama_2023_2L33.csv,ILF3_HUMAN,Human,Homo sapiens,MLTKHGKNPVMELNEKRRGLKYELISETGGSHDKRFVMEVEVDGQKFQGAGSNKKVAKAYAALAALEKLFP,71,FALSE,1329,1329,0,-0.4,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-23,Jan-71,Interleukin enhancer-binding factor 3,Stability,cDNA display proteolysis,ILF3_HUMAN_2023-08-07_b03.a2m,1,71,71,0.3,0.2,145438,0.915,65,21228,"3,265,846,154",High,57,0.876923077,Tsuboyama2023_Dataset2_Dataset20,ddG_ML_float,1,mut_type,ILF3_HUMAN_theta0.2_2023-08-07_b03.npy,ILF3_HUMAN.pdb,1,,Stability
KCNE1_HUMAN_Muhammad_2023_expression,KCNE1_HUMAN_Muhammad_2023_expression.csv,KCNE1_HUMAN,Human,Homo sapiens,MILSNTTAVTPFLTKLWQETVQQGGNMSGLARRSPRSGDGKLEALYVLMVLGFFGFFTLGIMLSYIRSKKLEHSNDPFNVYIESDAWQEKDKAYVQARVLESYRSCYVVENHLAIEQPNTHLPETKPSP,129,FALSE,2339,2339,0,0.75,manual,Muhammad,"High-throughput functional mapping of variants in an arrhythmia gene, KCNE1, reveals novel biology",2023,10.1101/2023.04.28.538612,1-128,KCNE1,cell surface expression,FACS,KCNE1_HUMAN_2023-08-07_b02.a2m,1,129,129,0.2,0.2,2118,0.969,125,213.7,"17,096",Medium,5,0.04,KCNE1_HUMAN_Muhammad_2023.csv,TrafScore,1,mutant,KCNE1_HUMAN_theta0.2_2023-08-07_b02.npy,KCNE1_HUMAN.pdb,1,,Expression
KCNH2_HUMAN_Kozek_2020,KCNH2_HUMAN_Kozek_2020.csv,KCNH2_HUMAN,Human,Homo sapiens,MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS,1159,FALSE,200,200,0,"5,887,492,867",median,Kozek,High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KCNH2: Deep mutational scan of KCNH2 trafficking,2020,10.1016/j.hrthm.2020.05.041,545-555,KCNH2,Voltage,Voltage,KCNH2_HUMAN_535-565_11-26-2021_b05.a2m,535,565,31,0.5,0.2,13907,1,31,186.6,"6,019,354,839",medium,1,0.032258065,KCNH2_HUMAN_Kozek_2020.csv,score.ave,1,var,KCNH2_HUMAN_theta_0.2.npy,KCNH2_HUMAN.pdb,0.1,,Activity
LYAM1_HUMAN_Elazar_2016,LYAM1_HUMAN_Elazar_2016.csv,LYAM1_HUMAN,Human,Homo sapiens,MIFPWKCQSTQRDLWNIFKLWGWTMLCCDFLAHHGTDCWTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGIWTWVGTNKSLTEEAENWGDGEPNNKKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTASCQPWSCSGHGECVEIINNYTCNCDVGYYGPQCQFVIQCEPLEAPELGTMDCTHPLGNFSFSSQCAFSCSEGTNLTGIEETTCGPFGNWSSPEPTCQVIQCEPLSAPDLGIMNCSHPLASFSFTSACTFICSEGTELIGKKKTICESSGIWSNPSPICQKLDKSFSMIKEGDYNPLFIPVAVMVTAFSGLAFIIWLARRLKKGKKSKRSMNDPY,372,FALSE,359,359,0,"1,306,138,768",median,Elazar,Mutational scanning reveals the determinants of protein insertion and association energetics in the plasma membrane,2016,10.7554/eLife.12125,333-355,L-selectin,Membrane-protein insertion,TOXCAT-Beta-lactamase (TbL) screen,LYAM1_HUMAN_2023-10-12_b04.a2m,1,372,372,0.4,0.2,3974,0.825,307,412.3,"1,342,996,743",Medium,41,0.133550489,urn_mavedb_00000051-a-1_scores.csv,score,-1,mutant,LYAM1_HUMAN_theta0.2_2023-10-12_b04.npy,LYAM1_HUMAN.pdb,1,332,Expression
MET_HUMAN_Estevam_2023,MET_HUMAN_Estevam_2023.csv,MET_HUMAN,Human,Homo sapiens,NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI,287,FALSE,5393,5393,0,-2,manual,Estevam,Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain,2023,10.1101/2023.08.03.551866,1-287,MET RTK,Human cell line with growth linked to kinase activity in the absense of IL-3,Growth,MET_HUMAN_2023-08-07_b09.a2m,1,287,287,0.9,0.2,185885,0.951,273,5338.5,"195,549,451",Medium,200,0.73,ex14_scores.csv,IL3_withdrawal_score,1,mutant,MET_HUMAN_theta0.2_2023-08-07_b09.npy,MET_HUMAN.pdb,1,,Activity
MK01_HUMAN_Brenan_2016,MK01_HUMAN_Brenan_2016.csv,MK01_HUMAN,Human,Homo sapiens,MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS,360,FALSE,6809,6809,0,"-8,040,790,936",median,Brenan,Phenotypic Characterization of a Comprehensive Set of MAPK1 /ERK2 Missense Mutants,2016,10.1016/j.celrep.2016.09.061,2-360,MAPK1,Growth,inhibitor resistance,MK01_HUMAN_full_11-26-2021_b06.a2m,1,360,360,0.6,0.2,124248,0.806,290,8815.9,"3,039,965,517",medium,287,0.989655172,MK01_HUMAN_Brenan_2016.csv,DOX_Average,-1,mutant,MK01_HUMAN_theta_0.2.npy,MK01_HUMAN.pdb,0.1,,OrganismalFitness
MSH2_HUMAN_Jia_2020,MSH2_HUMAN_Jia_2020.csv,MSH2_HUMAN,Human,Homo sapiens,MAVQPKETLQLESAAEVGFVRFFQGMPEKPTTTVRLFDRGDFYTAHGEDALLAAREVFKTQGVIKYMGPAGAKNLQSVVLSKMNFESFVKDLLLVRQYRVEVYKNRAGNKASKENDWYLAYKASPGNLSQFEDILFGNNDMSASIGVVGVKMSAVDGQRQVGVGYVDSIQRKLGLCEFPDNDQFSNLEALLIQIGPKECVLPGGETAGDMGKLRQIIQRGGILITERKKADFSTKDIYQDLNRLLKGKKGEQMNSAVLPEMENQVAVSSLSAVIKFLELLSDDSNFGQFELTTFDFSQYMKLDIAAVRALNLFQGSVEDTTGSQSLAALLNKCKTPQGQRLVNQWIKQPLMDKNRIEERLNLVEAFVEDAELRQTLQEDLLRRFPDLNRLAKKFQRQAANLQDCYRLYQGINQLPNVIQALEKHEGKHQKLLLAVFVTPLTDLRSDFSKFQEMIETTLDMDQVENHEFLVKPSFDPNLSELREIMNDLEKKMQSTLISAARDLGLDPGKQIKLDSSAQFGYYFRVTCKEEKVLRNNKNFSTVDIQKNGVKFTNSKLTSLNEEYTKNKTEYEEAQDAIVKEIVNISSGYVEPMQTLNDVLAQLDAVVSFAHVSNGAPVPYVRPAILEKGQGRIILKASRHACVEVQDEIAFIPNDVYFEKDKQMFHIITGPNMGGKSTYIRQTGVIVLMAQIGCFVPCESAEVSIVDCILARVGAGDSQLKGVSTFMAEMLETASILRSATKDSLIIIDELGRGTSTYDGFGLAWAISEYIATKIGAFCMFATHFHELTALANQIPTVNNLHVTALTTEETLTMLYQVKKGVCDQSFGIHVAELANFPKHVIECAKQKALELEEFQYIGESQGYDIMEPAAKKCYLEREQGEKIIQEFLSKVKQMPFTEMSEENITIKLKQLKAEVIAKNNSFVNEIISRIKVTT,934,FALSE,16749,16749,0,1,manual,Jia,Massively parallel functional testing of MSH2 missense variants conferring Lynch Syndrome risk,2020,10.1016/j.ajhg.2020.12.003,1-934,MSH2,"drug resistance (surrogate for protein activity, 6-thioguanine (6-TG))",,MSH2_HUMAN_full_11-26-2021_b05.a2m,1,934,934,0.5,0.2,61226,0.901,842,10716.4,"1,272,731,591",medium,1035,"1,229,216,152",MSH2_HUMAN_Jia_2020.csv,LOF score,-1,Variant,MSH2_HUMAN_theta_0.2.npy,MSH2_HUMAN.pdb,0.1,,OrganismalFitness
MTHR_HUMAN_Weile_2021,MTHR_HUMAN_Weile_2021.csv,MTHR_HUMAN,Human,Homo sapiens,MVNEARGNSSLNPCLEGSASSGSESSKDSSRCSTPGLDPERHERLREKMRRRLESGDKWFSLEFFPPRTAEGAVNLISRFDRMAAGGPLYIDVTWHPAGDPGSDKETSSMMIASTAVNYCGLETILHMTCCRQRLEEITGHLHKAKQLGLKNIMALRGDPIGDQWEEEEGGFNYAVDLVKHIRSEFGDYFDICVAGYPKGHPEAGSFEADLKHLKEKVSAGADFIITQLFFEADTFFRFVKACTDMGITCPIVPGIFPIQGYHSLRQLVKLSKLEVPQEIKDVIEPIKDNDAAIRNYGIELAVSLCQELLASGLVPGLHFYTLNREMATTEVLKRLGMWTEDPRRPLPWALSAHPKRREEDVRPIFWASRPKSYIYRTQEWDEFPNGRWGNSSSPAFGELKDYYLFYLKSKSPKEELLKMWGEELTSEESVFEVFVLYLSGEPNRNGHKVTCLPWNDEPLAAETSLLKEELLRVNRQGILTINSQPNINGKPSSDPIVGWGPSGGYVFQKAYLEFFTSRETAEALLQVLKKYELRVNYHLVNVKGENITNAPELQPNAVTWGIFPGREIIQPTVVDPVSFMFWKDEAFALWIERWGKLYEEESPSRTIIQYIHDNYFLVNLVDNDFPLDNCLWQVVEDTLELLNRPTQNARETEAP,656,FALSE,12464,12464,0,0.746,median,Weile,Shifting landscapes of human MTHFR missense-variant effects,2021,10.1016/j.ajhg.2021.05.009,1-656,MTHFR reductase,Growth,,MTHR_HUMAN_2023-08-07_b02.a2m,1,656,656,0.2,0.2,4783,0.96,630,614.5,0.975396825,Low,65,0.103174603,urn_mavedb_00000049-a-6_scores.csv,score,1,mutant,MTHR_HUMAN_theta0.2_2023-08-07_b02.npy,MTHR_HUMAN.pdb,1,,OrganismalFitness
NKX31_HUMAN_Tsuboyama_2023_2L9R,NKX31_HUMAN_Tsuboyama_2023_2L9R.csv,NKX31_HUMAN,Human,Homo sapiens,HSHMSHTQVIELERKFSHQKYLSAPERAHLAKNLKLTETQVKIWFQNRRYKTKRKQLSSEL,61,TRUE,2482,1149,1333,-0.3,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-28,Jan-61,Homeobox protein Nkx-3.1,Stability,cDNA display proteolysis,NKX31_HUMAN_2023-08-07_b04.a2m,1,61,61,0.4,0.2,319273,0.902,55,8440.8,"1,534,690,909",High,27,0.490909091,Tsuboyama2023_Dataset2_Dataset25,ddG_ML_float,1,mut_type,NKX31_HUMAN_theta0.2_2023-08-07_b04.npy,NKX31_HUMAN.pdb,1,,Stability
NPC1_HUMAN_Erwood_2022_HEK293T,NPC1_HUMAN_Erwood_2022_HEK293T.csv,NPC1_HUMAN,Human,Homo sapiens,MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHMKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNF,1278,FALSE,637,637,0,0.8,manual,Erwood,Saturation variant interpretation using CRISPR prime editing,2022,10.1038/s41587-021-01201-1,347-1190,NPC intracellular cholesterol transporter,Fluorescence measurement,Flow Cytometry Assay,NPC1_HUMAN_2023-10-12_b07.a2m,1,1278,1278,0.7,0.2,6333,0.987,1261,918.9,0.728707375,Low,137,0.108643933,41587_2021_1201_MOESM3_ESM.xlsx,Function Score,1,Protein Annotation,NPC1_HUMAN_theta0.2_2023-10-12_b07.npy,NPC1_HUMAN.pdb,1,,Activity
NUD15_HUMAN_Suiter_2020,NUD15_HUMAN_Suiter_2020.csv,NUD15_HUMAN,Human,Homo sapiens,MTASAQPRGRRPGVGVGVVVTSCKHPRCVLLGKRKGSVGAGSFQLPGGHLEFGETWEECAQRETWEEAALHLKNVHFASVVNSFIEKENYHYVTILMKGEVDVTHDSEPKNVEPEKNESWEWVPWEELPPLDQLFWGLRCLKEQGYDPFKEDLNHLVGYKGNHL,164,FALSE,2844,2844,0,0.25,manual,Suiter,Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity,2020,10.1073/pnas.1915680117,2-164,NUDT15,,"VAMP-seq, drug sensitivity",NUD15_HUMAN_full_11-26-2021_b04.a2m,1,164,164,0.4,0.2,153922,0.72,118,43847.8,"3,715,915,254",high,151,"1,279,661,017",NUD15_HUMAN_Suiter_2020.csv,Final NUDT15 activity Score,1,mutant,NUD15_HUMAN_theta_0.2.npy,NUD15_HUMAN.pdb,0.1,,Expression
OBSCN_HUMAN_Tsuboyama_2023_1V1C,OBSCN_HUMAN_Tsuboyama_2023_1V1C.csv,OBSCN_HUMAN,Human,Homo sapiens,FDIYVVTADYLPLGAEQDAITLREGQYVEVLDAAHPLRWLVRTKPTKSSPSRQGWVSPAYLDRRL,65,TRUE,3197,1213,1984,-1,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-31,Jan-65,Obscurin,Stability,cDNA display proteolysis,OBSCN_HUMAN_2023-08-07_b02.a2m,1,65,65,0.2,0.2,718751,0.815,53,23710.7,"4,473,716,981",High,54,"1,018,867,925",Tsuboyama2023_Dataset2_Dataset28,ddG_ML_float,1,mut_type,OBSCN_HUMAN_theta0.2_2023-08-07_b02.npy,OBSCN_HUMAN.pdb,1,,Stability
OPSD_HUMAN_Wan_2019,OPSD_HUMAN_Wan_2019.csv,OPSD_HUMAN,Human,Homo sapiens,MNGTEGPNFYVPFSNATGVVRSPFEYPQYYLAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVLGGFTSTLYTSLHGYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLAGWSRYIPEGLQCSCGIDYYTLKPEVNNESFVIYMFVVHFTIPMIIIFFCYGQLVFTVKEAAAQQQESATTQKAEKEVTRMVIIMVIAFLICWVPYASVAFYIFTHQGSNFGPIFMTIPAFFAKSAAIYNPVIYIMMNKQFRNCMLTTICCGKNPLGDDEASATVSKTETSQVAPA,348,FALSE,165,165,0,0.579514491,median,Wan,Characterizing variants of unknown significance in rhodopsin: A functional genomics approach,2019,10.1002/humu.23762,4-347,Rhodopsin,Expression,Flow Cytometry Assay,OPSD_HUMAN_2023-10-12_b04.a2m,1,348,348,0.4,0.2,342311,0.876,305,36900.5,"1,209,852,459",High,247,0.809836066,urn_mavedb_00000099-a-1_scores.csv,score,1,mutant,OPSD_HUMAN_theta0.2_2023-10-12_b04.npy,OPSD_HUMAN.pdb,1,,Expression
OTC_HUMAN_Lo_2023,OTC_HUMAN_Lo_2023.csv,OTC_HUMAN,Human,Homo sapiens,MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF,354,FALSE,1570,1570,0,0.417,median,Lo,"The functional impact of 1,570 individual amino acid substitutions in human OTC",2023,10.1016/j.ajhg.2023.03.019,33-354,OTC,Enzymatic activity,,OTC_HUMAN_2023-08-07_b02.a2m,1,354,354,0.2,0.2,135607,0.87,308,18646.2,"6,053,961,039",Medium,641,"2,081,168,831",urn_mavedb_00000112-a-1_scores.csv,DMS_score,1,mutant,OTC_HUMAN_theta0.2_2023-08-07_b02.npy,OTC_HUMAN.pdb,1,,Activity
OTU7A_HUMAN_Tsuboyama_2023_2L2D,OTU7A_HUMAN_Tsuboyama_2023_2L2D.csv,OTU7A_HUMAN,Human,Homo sapiens,TLDMDAVLSDFVRSTGAEPGLARDLLEGKNWDLTAALSDYEQ,42,FALSE,635,635,0,-1,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-33,Jan-42,OTU domain-containing protein 7A,Stability,cDNA display proteolysis,OTU7A_HUMAN_2023-08-07_b02.a2m,1,42,42,0.2,0.2,1359071,0.881,37,514715.2,"1,391,122,162",High,28,0.756756757,Tsuboyama2023_Dataset2_Dataset30,ddG_ML_float,1,mut_type,OTU7A_HUMAN_theta0.2_2023-08-07_b02.npy,OTU7A_HUMAN.pdb,1,,Stability
P53_HUMAN_Giacomelli_2018_WT_Nutlin,P53_HUMAN_Giacomelli_2018_WT_Nutlin.csv,P53_HUMAN,Human,Homo sapiens,MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPRVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD,393,FALSE,7467,7467,0,-1,manual,Giacomelli,Mutational processes shape the landscape of TP53 mutations in human cancer,2018,10.1038/s41588-018-0204-y,1-393,p53,"drug resistance (nutlin-3, etoposide)",Growth,P53_HUMAN_full_04-29-2022_b09.a2m,1,393,393,0.9,0.2,5069,0.858,337,153.2,0.454599407,low,7,0.020771513,P53_HUMAN_Giacomelli_2018.csv,A549_p53WT_Nutlin-3_Z-score,-1,Allele,P53_HUMAN_theta_0.2.npy,P53_HUMAN.pdb,0.1,,OrganismalFitness
PAI1_HUMAN_Huttinger_2021,PAI1_HUMAN_Huttinger_2021.csv,PAI1_HUMAN,Human,Homo sapiens,MQMSPALTCLVLGLALVFGEGSAVHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP,402,FALSE,5345,5345,0,0.029313547,median,Huttinger,Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape,2021,10.1038/s41598-021-97871-7,24-402,"PAI-1, SERPINE1",PAI-1 inhibition of uPA,phage fitness,PAI1_HUMAN_2023-10-12_b05.a2m,1,402,402,0.5,0.2,52528,,,,,,,,PAI1_HUMAN_Huttinger_2021,log2FoldChange,1,mutation,PAI1_HUMAN_theta0.2_2023-10-12_b05.npy,PAI1_HUMAN.pdb,1,,Activity
PIN1_HUMAN_Tsuboyama_2023_1I6C,PIN1_HUMAN_Tsuboyama_2023_1I6C.csv,PIN1_HUMAN,Human,Homo sapiens,KLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSG,39,TRUE,802,686,116,-0.684442047,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-34,Jan-39,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,Stability,cDNA display proteolysis,PIN1_HUMAN_2023-08-07_b02.a2m,1,39,39,0.2,0.2,248269,0.821,32,10833.2,"3,385,375",High,13,0.40625,Tsuboyama2023_Dataset2_Dataset31,ddG_ML_float,1,mut_type,PIN1_HUMAN_theta0.2_2023-08-07_b02.npy,PIN1_HUMAN.pdb,1,,Stability
PITX2_HUMAN_Tsuboyama_2023_2L7M,PITX2_HUMAN_Tsuboyama_2023_2L7M.csv,PITX2_HUMAN,Human,Homo sapiens,THFTSQQLQELEATFQRNHYPDMSTREEIAVWTNLTEARVRVWFKNRRAKWR,52,TRUE,1824,938,886,"-1,201,366,007",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-35,Jan-52,Pituitary homeobox 2,Stability,cDNA display proteolysis,PITX2_HUMAN_2023-08-07_b04.a2m,1,52,52,0.4,0.2,344174,1,52,9819.6,"1,888,384,615",High,25,0.480769231,Tsuboyama2023_Dataset2_Dataset32,ddG_ML_float,1,mut_type,PITX2_HUMAN_theta0.2_2023-08-07_b04.npy,PITX2_HUMAN.pdb,1,,Stability
PKN1_HUMAN_Tsuboyama_2023_1URF,PKN1_HUMAN_Tsuboyama_2023_1URF.csv,PKN1_HUMAN,Human,Homo sapiens,GIPATNLSRVAGLEKQLAIELKVKQGAENMIQTYSNGSTKDRKLLLTAQQMLQDSKTKIDIIRMQLRRALQ,71,FALSE,1301,1301,0,-0.5,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-36,Jan-71,Serine/threonine-protein kinase N1,Stability,cDNA display proteolysis,PKN1_HUMAN_2023-08-07_b01.a2m,1,71,71,0.1,0.2,187829,0.845,60,53755.8,895.93,High,13,0.216666667,Tsuboyama2023_Dataset2_Dataset33,ddG_ML_float,1,mut_type,PKN1_HUMAN_theta0.2_2023-08-07_b01.npy,PKN1_HUMAN.pdb,1,,Stability
PPARG_HUMAN_Majithia_2016,PPARG_HUMAN_Majithia_2016.csv,PPARG_HUMAN,Human,Homo sapiens,MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY,505,FALSE,9576,9576,0,-2.5,manual,Majithia,Prospective functional classification of all possible missense variants in PPARG,2016,10.1038/ng.3700,2-505,PPARG,Expression of CD36,FACS,PPARG_HUMAN_2023-10-12_b04.a2m,1,505,505,0.4,0.2,39993,0.8,404,3092.1,"7,653,712,871",Medium,86,0.212871287,https://miter.broadinstitute.org/mitergrade/?query=p.Y505A&prevalence=1.0e-5,Experimental function score,1,mutant,PPARG_HUMAN_theta0.2_2023-10-12_b04.npy,PPARG_HUMAN.pdb,1,,Activity
PPM1D_HUMAN_Miller_2022,PPM1D_HUMAN_Miller_2022.csv,PPM1D_HUMAN,Human,Homo sapiens,MAGLYSLGVSVFSDQGGRKYMEDVTQIVVEPEPTAEEKPSPRRSLSQPLPPRPSPAALPGGEVSGKGPAVAAREARDPLPDAGASPAPSRCCRRRSSVAFFAVCDGHGGREAAQFAREHLWGFIKKQKGFTSSEPAKVCAAIRKGFLACHLAMWKKLAEWPKTMTGLPSTSGTTASVVIIRGMKMYVAHVGDSGVVLGIQDDPKDDFVRAVEVTQDHKPELPKERERIEGLGGSVMNKSGVNRVVWKRPRLTHNGPVRRSTVIDQIPFLAVARALGDLWSYDFFSGEFVVSPEPDTSVHTLDPQKHKYIILGSDGLWNMIPPQDAISMCQDQEEKKYLMGEHGQSCAKMLVNRALGRWRQRMLRADNTSAIVICISPEVDNQGNFTNEDELYLNLTDSPSYNSQETCVMTPSPCSTPPVKSLEEDPWPRVNSKDHIPALVRSNAFSENFLEVSAEIARENVQGVVIPSKDPEPLEENCAKALTLRIHDSLNNSLPIGLVPTNSTNTVMDQKNLKMSTPGQMKAQEIERTPPTNFKRTLEESNSGPLMKKHRRNGLSRSSGAQPASLPTTSQRKNSVKLTMRRRLRGQKKIGNPLLHQHRKTVCVC,605,FALSE,7889,7889,0,0.01275,median,Miller,Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state,2022,10.1038/s41467-022-30463-9,2-421,Protein phosphatase 1D,Fitness with GFP reporter,quantification and selection of GFP-positive cells by flow cytometry after DNA damage induced by daunorubicin,PPM1D_HUMAN_2023-10-12_b01.a2m,1,605,605,0.1,0.2,1844,0.993,601,346.3,0.576206323,Low,27,0.044925125,PPM1D_HUMAN_Miller_2022_raw.xlsx,fitness,1,mutant,PPM1D_HUMAN_theta0.2_2023-10-12_b01.npy,PPM1D_HUMAN.pdb,1,,OrganismalFitness
PR40A_HUMAN_Tsuboyama_2023_1UZC,PR40A_HUMAN_Tsuboyama_2023_1UZC.csv,PR40A_HUMAN,Human,Homo sapiens,TYTWNTKEEAKQAFKELLKEKRVPSNASWEQAMKMIINDPRYSALAKLSEKKQAFNAYKVQTE,63,TRUE,2033,1163,870,"-1,362,579,422",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-38,Jan-63,Pre-mRNA-processing factor 40 homolog A,Stability,cDNA display proteolysis,PR40A_HUMAN_2023-08-07_b03.a2m,1,63,63,0.3,0.2,63560,0.857,54,3663.8,"6,784,814,815",Medium,16,0.296296296,Tsuboyama2023_Dataset2_Dataset35,ddG_ML_float,1,mut_type,PR40A_HUMAN_theta0.2_2023-08-07_b03.npy,PR40A_HUMAN.pdb,1,,Stability
PRKN_HUMAN_Clausen_2023,PRKN_HUMAN_Clausen_2023.csv,PRKN_HUMAN,Human,Homo sapiens,MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRKGQEMNATGGDDPRNAAGGCEREPQSLTRVDLSSSVLPGDSVGLAVILHTDSRKDSPPAGSPAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV,465,FALSE,8756,8756,0,0.75,manual,Clausen,A mutational atlas for Parkin proteostasis,2023,10.1101/2023.06.08.544160,1-465,Parkin,protein stability,FACS,PRKN_HUMAN_2023-08-07_b05.a2m,1,465,465,0.5,0.2,1457,0.998,464,195.2,0.420689655,Low,21,0.045258621,urn_mavedb_00000114-a-1_scores.csv,score,1,mutant,PRKN_HUMAN_theta0.2_2023-08-07_b05.npy,PRKN_HUMAN.pdb,1,,Expression
PTEN_HUMAN_Mighell_2018,PTEN_HUMAN_Mighell_2018.csv,PTEN_HUMAN,Human,Homo sapiens,MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLELIKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQEALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMFETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVCGDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEIDSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKTVEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQITKV,403,FALSE,7260,7260,0,-1.5,manual,Mighell,A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships,2018,10.1016/j.ajhg.2018.03.018,1-403,PTEN,"growth (surrogate for enzymatic activity/hydrolysis of lipid phosphates to restore PIP2, which affects proliferation rate)",lipid phosphatase activity,PTEN_HUMAN_full_11-26-2021_b01.a2m,1,403,403,0.1,0.2,19058,0.752,303,1425.3,"4,703,960,396",medium,52,0.171617162,PTEN_HUMAN_Mighell_2018.csv,Fitness_score,1,mutant,PTEN_HUMAN_theta_0.2.npy,PTEN_HUMAN.pdb,0.1,,Activity
RAF1_HUMAN_Zinkus-Boltz_2019,RAF1_HUMAN_Zinkus-Boltz_2019.csv,RAF1_HUMAN,Human,Homo sapiens,MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF,648,FALSE,297,297,0,-0.0671,median,Zinkus-Boltz,A Phage-Assisted Continuous Selection Approach for Deep Mutational Scanning of Protein‚ÄìProtein Interactions,2019,10.1021/acschembio.9b00669,52-90,RAF oncogene,Viral Replication,binding assays,RAF1_HUMAN_2023-10-12_b05.a2m,1,648,648,0.5,0.2,9685,0.972,630,350.5,0.556349206,Low,30,0.047619048,urn_mavedb_00000061-a-1_scores.csv,score,1,mutant,RAF1_HUMAN_theta0.2_2023-10-12_b05.npy,RAF1_HUMAN.pdb,1,,OrganismalFitness
RASH_HUMAN_Bandaru_2017,RASH_HUMAN_Bandaru_2017.csv,RASH_HUMAN,Human,Homo sapiens,MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS,189,FALSE,3134,3134,0,-0.25,manual,Bandaru,Deconstruction of the Ras switching cycle through saturation mutagenesis,2017,10.7554/eLife.27810,2-166,HRAS,C-Raf binding and GEF,activity,RASH_HUMAN_full_11-26-2021_b03.a2m,1,189,189,0.3,0.2,204751,0.862,163,23971.6,"1,470,650,307",high,205,"1,257,668,712",RASH_HUMAN_Bandaru_2017.csv,unregulated,1,mutant,RASH_HUMAN_theta_0.2.npy,RASH_HUMAN.pdb,0.1,,Activity
RASK_HUMAN_Weng_2022_binding-DARPin_K55,RASK_HUMAN_Weng_2022_binding-DARPin_K55.csv,RASK_HUMAN,Human,Human,MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSKDGKKKKKKSKTKCVIM,188,TRUE,24873,3084,21789,-0.460545526,median,Weng,The energetic and allosteric landscape for KRAS inhibition,2022,10.1101/2022.12.06.519127,2-188,KRAS,Yeast growth,,RASK_HUMAN_2023-08-07_b03.a2m,1,188,188,0.3,0.2,260539,0.888,167,27850.5,"1,667,694,611",High,211,"1,263,473,054",kras_fitness.xlsx,fitness,1,mutant,RASK_HUMAN_theta0.2_2023-08-07_b03.npy,RASK_HUMAN.pdb,1,,Binding
RBP1_HUMAN_Tsuboyama_2023_2KWH,RBP1_HUMAN_Tsuboyama_2023_2KWH.csv,RBP1_HUMAN,Human,Homo sapiens,ETQAGIKEEIRRQEFLLNSLHRDLQGGIKDLSKEERLWEVQRILTALKRKLR,52,TRUE,1332,975,357,-0.26931899,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-41,Jan-52,RalA-binding protein 1,Stability,cDNA display proteolysis,RBP1_HUMAN_2023-08-07_b01.a2m,1,52,52,0.1,0.2,135922,0.827,43,50510,"1,174,651,163",High,6,0.139534884,Tsuboyama2023_Dataset2_Dataset38,ddG_ML_float,1,mut_type,RBP1_HUMAN_theta0.2_2023-08-07_b01.npy,RBP1_HUMAN.pdb,1,,Stability
RD23A_HUMAN_Tsuboyama_2023_1IFY,RD23A_HUMAN_Tsuboyama_2023_1IFY.csv,RD23A_HUMAN,Human,Homo sapiens,SEYETMLTEIMSMGYERERVVAALRASYNNPHRAVEYLLTGIPG,44,TRUE,1019,798,221,-0.728520528,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-44,Jan-44,UV excision repair protein RAD23 homolog A,Stability,cDNA display proteolysis,RD23A_HUMAN_2023-08-07_b04.a2m,1,44,44,0.4,0.2,100991,0.864,38,7912.9,"2,082,342,105",High,21,0.552631579,Tsuboyama2023_Dataset2_Dataset41,ddG_ML_float,1,mut_type,RD23A_HUMAN_theta0.2_2023-08-07_b04.npy,RD23A_HUMAN.pdb,1,,Stability
S22A1_HUMAN_Yee_2023_activity,S22A1_HUMAN_Yee_2023_activity.csv,S22A1_HUMAN,Human,Homo sapiens,PTVDDILEQVGESGWFQKQAFLILCLLSAAFAPICVGIVFLGFTPDHHCQSPGVAELSQRCGWSPAEELNYTVPGLGPAGEAFLGQCRRYEVDWNQSALSCVDPLASLATNRSHLPLGPCQDGWVYDTPGSSIVTEFNLVCADSWKLDLFQSCLNAGFLFGSLGVGYFADRFGRKLCLLGTVLVNAVSGVLMAFSPNYMSMLLFRLLQGLVSKGNWMAGYTLITEFVGSGSRRTVAIMYQMAFTVGLVALTGLAYALPHWRWLQLAVSLPTFLFLLYYWCVPESPRWLLSQKRNTEAIKIMDHIAQKNGKLPPADLKMLSLEEDVTEKLSPSFADLFRTPRLRKRTFILMYLWFTDSVLYQGLILHMGATSGNLYLDFLYSALVEIPGAFIALITIDRVGRIYPMAMSNLLAGAACLVMIFISPDLHWLNIIIMCVGRMGITIAIQMICLVNAELYPTFVRNLGVMVCSSLCDIGGIITPFIVFRLREVWQALPLILFAVLGLLAAGVTLLLPETKGVALPETMKDAENLGRKAKPKENTIYLKVQTSEPSGT,553,FALSE,10094,10094,0,1,manual,Yee,The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomics,2023,10.1101/2023.06.06.543963,1-549,Oct-01,uptake of cytotoxic substrate,Growth,S22A1_HUMAN_2023-08-07_b02.a2m,1,553,553,0.2,0.2,198790,0.807,446,32557.5,"7,299,887,892",Medium,485,"1,087,443,946",543963_file04.xlsx,SM73_1_score,-1,mutant,S22A1_HUMAN_theta0.2_2023-08-07_b02.npy,S22A1_HUMAN.pdb,1,,Activity
SC6A4_HUMAN_Young_2021,SC6A4_HUMAN_Young_2021.csv,SC6A4_HUMAN,Human,Homo sapiens,METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIHRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRICWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIITPGTFKERIIKSITPETPTEIPCGDIRLNAV,630,FALSE,11576,11576,0,-0.156068832,median,Young,Deep Mutagenesis of a Transporter for Uptake of a Non-Native Substrate Identifies Conformationally Dynamic Regions,2021,10.1101/2021.04.19.440442,2-630,Sodium-dependent serotonin transporter,Fluorescence,Fluorescence,SC6A4_HUMAN_full_11-26-2021_b02.a2m,1,630,630,0.2,0.2,40971,0.805,507,5278.9,"1,041,203,156",medium,278,0.548323471,SC6A4_HUMAN_Young_2021.csv,avg_MYC,1,mutant,SC6A4_HUMAN_theta_0.2.npy,SC6A4_HUMAN.pdb,0.1,,Activity
SCN5A_HUMAN_Glazer_2019,SCN5A_HUMAN_Glazer_2019.csv,SCN5A_HUMAN,Human,Homo sapiens,MANFLLPRGTSSFRRFTRESLAAIEKRMAEKQARGSTTLQESREGLPEEEAPRPQLDLQASKKLPDLYGNPPQELIGEPLEDLDPFYSTQKTFIVLNKGKTIFRFSATNALYVLSPFHPIRRAAVKILVHSLFNMLIMCTILTNCVFMAQHDPPPWTKYVEYTFTAIYTFESLVKILARGFCLHAFTFLRDPWNWLDFSVIIMAYTTEFVDLGNVSALRTFRVLRALKTISVISGLKTIVGALIQSVKKLADVMVLTVFCLSVFALIGLQLFMGNLRHKCVRNFTALNGTNGSVEADGLVWESLDLYLSDPENYLLKNGTSDVLLCGNSSDAGTCPEGYRCLKAGENPDHGYTSFDSFAWAFLALFRLMTQDCWERLYQQTLRSAGKIYMIFFMLVIFLGSFYLVNLILAVVAMAYEEQNQATIAETEEKEKRFQEAMEMLKKEHEALTIRGVDTVSRSSLEMSPLAPVNSHERRSKRRKRMSSGTEECGEDRLPKSDSEDGPRAMNHLSLTRGLSRTSMKPRSSRGSIFTFRRRDLGSEADFADDENSTAGESESHHTSLLVPWPLRRTSAQGQPSPGTSAPGHALHGKKNSTVDCNGVVSLLGAGDPEATSPGSHLLRPVMLEHPPDTTTPSEEPGGPQMLTSQAPCVDGFEEPGARQRALSAVSVLTSALEELEESRHKCPPCWNRLAQRYLIWECCPLWMSIKQGVKLVVMDPFTDLTITMCIVLNTLFMALEHYNMTSEFEEMLQVGNLVFTGIFTAEMTFKIIALDPYYYFQQGWNIFDSIIVILSLMELGLSRMSNLSVLRSFRLLRVFKLAKSWPTLNTLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKNYSELRDSDSGLLPRWHMMDFFHAFLIIFRILCGEWIETMWDCMEVSGQSLCLLVFLLVMVIGNLVVLNLFLALLLSSFSADNLTAPDEDREMNNLQLALARIQRGLRFVKRTTWDFCCGLLRQRPQKPAALAAQGQLPSCIATPYSPPPPETEKVPPTRKETRFEEGEQPGQGTPGDPEPVCVPIAVAESDTDDQEEDEENSLGTEEESSKQQESQPVSGGPEAPPDSRTWSQVSATASSEAEASASQADWRQQWKAEPQAPGCGETPEDSCSEGSTADMTNTAELLEQIPDLGQDVKDPEDCFTEGCVRRCPCCAVDTTQAPGKVWWRLRKTCYHIVEHSWFETFIIFMILLSSGALAFEDIYLEERKTIKVLLEYADKMFTYVFVLEMLLKWVAYGFKKYFTNAWCWLDFLIVDVSLVSLVANTLGFAEMGPIKSLRTLRALRPLRALSRFEGMRVVVNALVGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFGRCINQTEGDLPLNYTIVNNKSQCESLNLTGELYWTKVKVNFDNVGAGYLALLQVATFKGWMDIMYAAVDSRGYEEQPQWEYNLYMYIYFVIFIIFGSFFTLNLFIGVIIDNFNQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPLNKYQGFIFDIVTKQAFDVTIMFLICLNMVTMMVETDDQSPEKINILAKINLLFVAIFTGECIVKLAALRHYYFTNSWNIFDFVVVILSIVGTVLSDIIQKYFFSPTLFRVIRLARIGRILRLIRGAKGIRTLLFALMMSLPALFNIGLLLFLVMFIYSIFGMANFAYVKWEAGIDDMFNFQTFANSMLCLFQITTSAGWDGLLSPILNTGPPYCDPTLPNSNGSRGDCGSPAVGILFFTTYIIISFLIVVNMYIAIILENFSVATEESTEPLSEDDFDMFYEIWEKFDPEATQFIEYSVLSDFADALSEPLRIAKPNQISLINMDLPMVSGDRIHCMDILFAFTKRVLGESGEMDALKIQMEEKFMAANPSKISYEPITTTLRRKHEEVSAMVIQRAFRRHLLQRSLKHASFLFRQQAGSGLSEEDAPEREGLIAYVMSENFSRPLGPPSSSSISSTSFPPSYDSVTRATSDNLQVRGSDYSHSEDLADFPPSPDRDRESIV,2016,FALSE,224,224,0,-88.35,median,Glazer,Deep Mutational Scan of an SCN5A Voltage Sensor,2019,10.1161/CIRCGEN.119.002786,1621-1632,SCN5A,"drug resistance (triple-drug assay: veratridine + brevetoxin + ouabain; surrogate for sodium channel dysfunction, select against function)",,SCN5A_HUMAN_1611-1642_11-26-2021_b03.a2m,1611,1642,32,0.3,0.2,49973,0.812,26,743.1,"2,858,076,923",medium,2,0.076923077,SCN5A_HUMAN_Glazer_2019.csv,dms,-1,mutation,SCN5A_HUMAN_theta_0.2.npy,SCN5A_HUMAN.pdb,0.1,,OrganismalFitness
SERC_HUMAN_Xie_2023,SERC_HUMAN_Xie_2023.csv,SERC_HUMAN,Human,Homo sapiens,MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLVRELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGTINIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSNFLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLYNTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSKMNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAFMKKFLEMHQL,370,FALSE,1914,1914,0,0.936065832,median,Xie,Predicting the functional effect of compound heterozygous genotypes from large scale variant effect maps,2023,10.1101/2023.01.11.523651,2-370,PSAT1,Yeast growth,,SERC_HUMAN_2023-08-07_b02.a2m,1,370,370,0.2,0.2,232438,0.949,351,42521.5,"1,211,438,746",High,899,"2,561,253,561",urn_mavedb_00000107-b-1_scores-2.csv,score,1,mutant,SERC_HUMAN_theta0.2_2023-08-07_b02.npy,SERC_HUMAN.pdb,1,,OrganismalFitness
SHOC2_HUMAN_Kwon_2022,SHOC2_HUMAN_Kwon_2022.csv,SHOC2_HUMAN,Human,Homo sapiens,MSSSLGKEKDSKEKDPKVPSAKEREKEAKASGGFGKESKEKEPKTKGKDAKDGKKDSSAAQPGVAFSVDNTIKRPNPAPGTRKKSSNAEVIKELNKCREENSMRLDLSKRSIHILPSSIKELTQLTELYLYSNKLQSLPAEVGCLVNLMTLALSENSLTSLPDSLDNLKKLRMLDLRHNKLREIPSVVYRLDSLTTLYLRFNRITTVEKDIKNLSKLSMLSIRENKIKQLPAEIGELCNLITLDVAHNQLEHLPKEIGNCTQITNLDLQHNELLDLPDTIGNLSSLSRLGLRYNRLSAIPRSLAKCSALEELNLENNNISTLPESLLSSLVKLNSLTLARNCFQLYPVGGPSQFSTIYSLNMEHNRINKIPFGIFSRAKVLSKLNMKDNQLTSLPLDFGTWTSMVELNLATNQLTKIPEDVSGLVSLEVLILSNNLLKKLPHGLGNLRKLRELDLEENKLESLPNEIAYLKDLQKLVLTNNQLTTLPRGIGHLTNLTHLGLGENLLTHLPEEIGTLENLEELYLNDNPNLHSLPFELALCSKLSIMSIENCPLSHLPPQIVAGGPSFIIQFLKMQGPYRAMV,582,FALSE,10972,10972,0,-0.34,median,Kwon,Structure‚Äìfunction analysis of the SHOC2‚ÄìMRAS‚ÄìPP1C holophosphatase complex,2022,10.1038/s41586-022-04928-2,2-582,Leucine-rich repeat protein SHOC-2,Drug resistance,Survival (dosed with trametinib),SHOC2_HUMAN_2023-10-12_b04.a2m,1,582,582,0.4,0.2,22163,0.777,452,8806.8,"194,840,708",Medium,379,0.838495575,2022.3.16.Extended Data Table 4.csv,LFC_scaled,1,variant.by.aa,SHOC2_HUMAN_theta0.2_2023-10-12_b04.npy,SHOC2_HUMAN.pdb,1,,OrganismalFitness
SOX30_HUMAN_Tsuboyama_2023_7JJK,SOX30_HUMAN_Tsuboyama_2023_7JJK.csv,SOX30_HUMAN,Human,Homo sapiens,RPMNAFMVWARIHRPALAKANPAANNAEISVQLGLEWNKLSEEQKKPYYDEAQKIKE,57,FALSE,1010,1010,0,-0.321640476,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-53,Jan-57,Transcription factor SOX-30,Stability,cDNA display proteolysis,SOX30_HUMAN_2023-08-07_b03.a2m,1,57,57,0.3,0.2,158104,0.982,56,14909.6,"2,662,428,571",High,36,0.642857143,Tsuboyama2023_Dataset2_Dataset50,ddG_ML_float,1,mut_type,SOX30_HUMAN_theta0.2_2023-08-07_b03.npy,SOX30_HUMAN.pdb,1,,Stability
SRBS1_HUMAN_Tsuboyama_2023_2O2W,SRBS1_HUMAN_Tsuboyama_2023_2O2W.csv,SRBS1_HUMAN,Human,Homo sapiens,GIDPFTGEAIAKFNFNGDTQVEMSFRKGERITLLRQVDENWYEGRIPGTSRQGIFPITYVDVIKRPL,67,TRUE,1556,1211,345,"-1,169,019,411",median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-59,Jan-67,Sorbin and SH3 domain-containing protein 1,Stability,cDNA display proteolysis,SRBS1_HUMAN_2023-08-07_b03.a2m,1,67,67,0.3,0.2,708655,0.836,56,22689,"4,051,607,143",High,60,"1,071,428,571",Tsuboyama2023_Dataset2_Dataset56,ddG_ML_float,1,mut_type,SRBS1_HUMAN_theta0.2_2023-08-07_b03.npy,SRBS1_HUMAN.pdb,1,,Stability
SRC_HUMAN_Chakraborty_2023_binding-DAS_25uM,SRC_HUMAN_Chakraborty_2023_binding-DAS_25uM.csv,SRC_HUMAN,Human,Homo sapiens,MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL,536,FALSE,3637,3637,0,-0.086077486,median,Chakraborty,Profiling of the drug resistance of thousands of Src tyrosine kinase mutants uncovers a regulatory network that couples autoinhibition to catalytic domain dynamics,2022,10.1101/2021.12.05.471322,270-519,SRC,Fluorescence measurement,,SRC_HUMAN_2023-08-07_b06.a2m,1,536,536,0.6,0.2,37675,0.869,466,1789,"3,839,055,794",Medium,117,0.251072961,GSE190495_Src_DAS_25_Score.csv,DMS_score,1,mutant,SRC_HUMAN_theta0.2_2023-08-07_b06.npy,SRC_HUMAN.pdb,1,,Activity
SUMO1_HUMAN_Weile_2017,SUMO1_HUMAN_Weile_2017.csv,SUMO1_HUMAN,Human,Homo sapiens,MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV,101,FALSE,1700,1700,0,0.3,manual,Weile,A framework for exhaustively mapping functional missense variants,2017,10.15252/msb.20177908,Feb-97,Small ubiquitin-related modifier 1,Yeast growth,complementation,SUMO1_HUMAN_full_11-26-2021_b02.a2m,1,101,101,0.2,0.2,85570,0.703,71,13120.2,"1,847,915,493",high,67,0.943661972,SUMO1_HUMAN_Weile_2017.csv,screenscore,1,mutant,SUMO1_HUMAN_theta_0.2.npy,SUMO1_HUMAN.pdb,0.1,,OrganismalFitness
SYUA_HUMAN_Newberry_2020,SYUA_HUMAN_Newberry_2020.csv,SYUA_HUMAN,Human,Homo sapiens,MDVYMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLFVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGYVKKDQLGKNEEGAPQEGILEDMPVDPDNEAFEMPSEEGFQDFEPEA,140,FALSE,2497,2497,0,-0.1,manual,Newberry,Robust Sequence Determinants of Œ±-Synuclein Toxicity in Yeast Implicate Membrane Binding,2020,10.1021/acschembio.0c00339,1-140,alpha-synuclein,Growth,Growth,SYUA_HUMAN_full_04-29-2022_b01.a2m,1,140,140,0.1,0.2,15711,0.707,99,6509.6,"6,575,353,535",medium,62,0.626262626,SYUA_HUMAN_Newberry_2020.csv,Fitness Score,-1,mutant,SYUA_HUMAN_theta_0.2.npy,SYUA_HUMAN.pdb,0.1,,OrganismalFitness
TADBP_HUMAN_Bolognesi_2019,TADBP_HUMAN_Bolognesi_2019.csv,TADBP_HUMAN,Human,Homo sapiens,MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKDNKRKMDETDASSAVKVKRAVQKTSDLIVLGLPWKTTEQDLKEYFSTFGEVLMVQVKKDLKTGHSKGFGFVRFTEYETQVKVMSQRHMIDGRWCDCKLPNSKQSQDEPLRSRKVFVGRCTEDMTEDELREFFSQYGDVMDVFIPKPFRAFAFVTFADDQIAQSLCGEDLIIKGISVHISNAEPKHNSNRQLERSGRFGGNPGGFGNQGGFGNSRGGGAGLGNNQGSNMGGGMNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQREPNQAFGSGNNSYSGSNSGAAIGWGSASNAGSGSGFNGGFGSSMDSKSSGWGM,414,FALSE,1196,1196,0,0.003661517,median,Bolognesi,The mutational landscape of a prion-like domain,2019,10.1038/s41467-019-12101-z,290-373,TARDBP,growth (surrogate for toxicity),Growth,TADBP_HUMAN_full_11-26-2021_b09.a2m,1,414,414,0.9,0.2,1211,0.911,377,147.3,0.39071618,low,8,0.021220159,TADBP_HUMAN_Bolognesi_2019.csv,toxicity,1,mutant_uniprot_1,TADBP_HUMAN_theta_0.2.npy,TADBP_HUMAN.pdb,0.1,,OrganismalFitness
TNKS2_HUMAN_Tsuboyama_2023_5JRT,TNKS2_HUMAN_Tsuboyama_2023_5JRT.csv,TNKS2_HUMAN,Human,Homo sapiens,FSITQFVRNLGLEHLMDIFEREQITLRVLVEMGHKELKEIGINAYGHREKLIKGVERLI,59,TRUE,1479,1118,361,-0.945120582,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-62,Jan-59,Poly [ADP-ribose] polymerase tankyrase-2,Stability,cDNA display proteolysis,TNKS2_HUMAN_2023-08-07_b03.a2m,1,59,59,0.3,0.2,270654,0.949,56,11206,"2,001,071,429",High,26,0.464285714,Tsuboyama2023_Dataset2_Dataset59,ddG_ML_float,1,mut_type,TNKS2_HUMAN_theta0.2_2023-08-07_b03.npy,TNKS2_HUMAN.pdb,1,,Stability
TPK1_HUMAN_Weile_2017,TPK1_HUMAN_Weile_2017.csv,TPK1_HUMAN,Human,Homo sapiens,MEHAFTPLEPLLSTGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLKVDVIVTLGGLAGRFDQIMASVNTLFQATHITPFPIIIIQEESLIYLLQPGKHRLHVDTGMEGDWCGLIPVGQPCMQVTTTGLKWNLTNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS,243,FALSE,3181,3181,0,0.5,manual,Weile,A framework for exhaustively mapping functional missense variants,2017,10.15252/msb.20177908,2-243,Thiamin pyrophosphokinase 1,Yeast growth,complementation,TPK1_HUMAN_full_11-26-2021_b02.a2m,1,243,243,0.2,0.2,21515,0.823,200,7122.6,"35,613",medium,234,Jan-17,TPK1_HUMAN_Weile_2017.csv,screenscore,1,mutant,TPK1_HUMAN_theta_0.2.npy,TPK1_HUMAN.pdb,0.1,,OrganismalFitness
TPMT_HUMAN_Matreyek_2018,TPMT_HUMAN_Matreyek_2018.csv,TPMT_HUMAN,Human,Homo sapiens,MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQDKWVNGKTAFHQEQGHQLLKKHLDTFLKGKSGLRVFFPLCGKAVEMKWFADRGHSVVGVEISELGIQEFFTEQNLSYSEEPITEIPGTKVFKSSSGNISLYCCSIFDLPRTNIGKFDMIWDRGALVAINPGDRKCYADTMFSLLGKKFQYLLCVLSYDPTKHPGPPFYVPHAEIERLFGKICNIRCLEKVDAFEERHKSWGIDCLFEKLYLLTEK,245,FALSE,3648,3648,0,0.5,manual,Matreyek,Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing,2018,10.1038/s41588-018-0122-z,1-245,Thiopurine S-methyltransferase,Protein abundance (FACS sorting for abundance of GFP-fused target),Protein stability,TPMT_HUMAN_full_11-26-2021_b03.a2m,1,245,245,0.3,0.2,19526,0.731,179,6296.8,"3,517,765,363",medium,109,0.608938548,TPMT_HUMAN_Matreyek_2018.csv,score,1,mutant,TPMT_HUMAN_theta_0.2.npy,TPMT_HUMAN.pdb,0.1,,Expression
TPOR_HUMAN_Bridgford_2020,TPOR_HUMAN_Bridgford_2020.csv,TPOR_HUMAN,Human,Homo sapiens,MPSWALFMVTSCLLLAPQNLAQVSSQDVSLLASDSEPLKCFSRTFEDLTCFWDEEEAAPSGTYQLLYAYPREKPRACPLSSQSMPHFGTRYVCQFPDQEEVRLFFPLHLWVKNVFLNQTRTQRVLFVDSVGLPAPPSIIKAMGGSQPGELQISWEEPAPEISDFLRYELRYGPRDPKNSTGPTVIQLIATETCCPALQRPHSASALDQSPCAQPTMPWQDGPKQTSPSREASALTAEGGSCLISGLQPGNSYWLQLRSEPDGISLGGSWGSWSLPVTVDLPGDAVALGLQCFTLDLKNVTCQWQQQDHASSQGFFYHSRARCCPRDRYPIWENCEEEEKTNPGLQTPQFSRCHFKSRNDSIIHILVEVTTAPGTVHSYLGSPFWIHQAVRLPTPNLHWREISSGHLELEWQHPSSWAAQETCYQLRYTGEGHQDWKVLEPPLGARGGTLELRPRSRYRLQLRARLNGPTYQGPWSSWSDPTRVETATETAWISLVTALHLVLGLNAVLGLLLLRWQFPAHYRRLRHALWPSLPDLHRVLGQYLRDTAALSPPKATVSDTCEEVEPSLLEILPKSSERTPLPLCSSQAQMDYRRLQPSCLGTMPLSVCPPMAESGSCCTTHIANHSYLPLSYWQQP,635,FALSE,562,562,0,-0.1,manual,Bridgford,Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning,2020,10.1182/blood.2019002561,487-517,MPL,growth/survival (surrogate for TpoR/MPL enhanced constitutive activation),Growth,TPOR_HUMAN_full_11-26-2021_b01.a2m,1,635,635,0.1,0.2,937,0.825,524,128.4,0.245038168,low,0,0,TPOR_HUMAN_Bridgford_S505N_2020.csv,score,1,mutant_uniprot_1,TPOR_HUMAN_theta_0.2.npy,TPOR_HUMAN.pdb,0.1,,OrganismalFitness
UBC9_HUMAN_Weile_2017,UBC9_HUMAN_Weile_2017.csv,UBC9_HUMAN,Human,Homo sapiens,MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPSY,159,FALSE,2563,2563,0,0.384407289,median,Weile,A framework for exhaustively mapping functional missense variants,2017,10.15252/msb.20177908,1-158,SUMO-conjugating enzyme UBC9,Yeast growth,complementation,UBC9_HUMAN_full_11-26-2021_b03.a2m,1,159,159,0.3,0.2,69788,0.849,135,8394,"6,217,777,778",medium,89,0.659259259,UBC9_HUMAN_Weile_2017.csv,screenscore,1,mutant,UBC9_HUMAN_theta_0.2.npy,UBC9_HUMAN.pdb,0.1,,OrganismalFitness
UBE4B_HUMAN_Tsuboyama_2023_3L1X,UBE4B_HUMAN_Tsuboyama_2023_3L1X.csv,UBE4B_HUMAN,Human,Homo sapiens,DAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSPTDPFNRQTLTESMLEPVPELKEQIQAWMR,69,TRUE,3622,1118,2504,-1,manual,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-63,Jan-69,Ubiquitin conjugation factor E4 B,Stability,cDNA display proteolysis,UBE4B_HUMAN_2023-08-07_b04.a2m,1,69,69,0.4,0.2,310943,0.928,64,34185.4,"534,146,875",High,52,0.8125,Tsuboyama2023_Dataset2_Dataset60,ddG_ML_float,1,mut_type,UBE4B_HUMAN_theta0.2_2023-08-07_b04.npy,UBE4B_HUMAN.pdb,1,,Stability
UBR5_HUMAN_Tsuboyama_2023_1I2T,UBR5_HUMAN_Tsuboyama_2023_1I2T.csv,UBR5_HUMAN,Human,Homo sapiens,HRQALGERLYPRVQAMQPAFASKITGMLLELSPAQLLLLLASEDSLRARVDEAMELII,58,TRUE,1453,1094,359,-0.446016544,median,Tsuboyama,Mega-scale experimental analysis of protein folding stability in biology and design,2023,10.1038/s41586-023-06328-64,Jan-58,E3 ubiquitin-protein ligase UBR5,Stability,cDNA display proteolysis,UBR5_HUMAN_2023-08-07_b05.a2m,1,58,58,0.5,0.2,17888,0.966,56,1031.7,"1,842,321,429",Medium,14,0.25,Tsuboyama2023_Dataset2_Dataset61,ddG_ML_float,1,mut_type,UBR5_HUMAN_theta0.2_2023-08-07_b05.npy,UBR5_HUMAN.pdb,1,,Stability
VKOR1_HUMAN_Chiasson_2020_abundance,VKOR1_HUMAN_Chiasson_2020_abundance.csv,VKOR1_HUMAN,Human,Homo sapiens,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,163,FALSE,2695,2695,0,0.748089337,median,Chiasson,"Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact",2020,10.7554/eLife.58026,2-163,VKORC1,protein abundance (eGFP fusion reporter),Fluorescence,VKOR1_HUMAN_full_11-26-2021_b03.a2m,1,163,163,0.3,0.2,14510,0.779,127,4655,"3,665,354,331",medium,97,0.763779528,VKOR1_HUMAN_Chiasson_2020.csv,abundance_score,1,variant,VKOR1_HUMAN_theta_0.2.npy,VKOR1_HUMAN.pdb,0.1,,Expression
YAP1_HUMAN_Araya_2012,YAP1_HUMAN_Araya_2012.csv,YAP1_HUMAN,Human,Homo sapiens,MDPGQQPPPQPAPQGQGQPPSQPPQGQGPPSGPGQPAPAATQAAPQAPPAGHQIVHVRGDSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPEPKSHSRQASTDAGTAGALTPQHVRAHSSPASLQLGAVSPGTLTPTGVVSGPAATPTAQHLRQSSFEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRKAMLSQMNVTAPTSPPVQQNMMNSASGPLPDGWEQAMTQDGEIYYINHKNKTTSWLDPRLDPRFAMNQRISQSAPVKQPPPLAPQSPQGGVMGGSNSNQQQQMRLQQLQMEKERLRLKQQELLRQAMRNINPSTANSPKCQELALRSQLPTLEQDGGTQNPVSSPGMSQELRTMTTNSSDPFLNSGTYHSRDESTDSGLSMSSYSVPRTPDDFLNSVDEMDTGDTINQSTLPSQQNRFPDYLEAIPGTNVDLGTLEGDGMNIEGEELMPSLQEALSSDILNDMESVLAATKLDKESFLTWL,504,TRUE,10075,362,9713,0.623640257,median,Araya,"A fundamental protein property, thermodynamic stability, revealed solely from large-scale measurements of protein function",2012,10.1073/pnas.1209751109,170-203,YAP1,peptide binding,Binding,YAP1_HUMAN_full_11-26-2021_b02.a2m,1,504,504,0.2,0.2,1604,0.859,433,132.6,0.306235566,low,1,0.002309469,YAP1_HUMAN_Araya_2012.csv,W,1,mutant,YAP1_HUMAN_theta_0.2.npy,YAP1_HUMAN.pdb,0.1,,Binding
